Cytarabine and Blast cell count increased - a phase IV clinical study of FDA data

Summary:

Blast cell count increased is reported as a side effect among people who take Cytarabine (cytarabine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Venclexta, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Blast cell count increased when taking Cytarabine. It is created by eHealthMe based on reports of 65,319 people who have side effects when taking Cytarabine from the FDA, and is updated regularly.

What is Cytarabine?

Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 65,358 Cytarabine users. Check the latest studies of Cytarabine.

What is Blast cell count increased?

Blast cell count increased is found to be associated with 113 drugs and 181 conditions by eHealthMe. Check the latest studies of Blast cell count increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

65,319 people reported to have side effects when taking Cytarabine.
Among them, 60 people (0.09%) have Blast cell count increased.

Could Cytarabine cause Blast cell count increased?

Among these 60 people:

How long have people been on Cytarabine when they have Blast cell count increased? *

What is the gender of people who have Blast cell count increased when taking Cytarabine? *

female: 31.37 %
male: 68.63 %

What is the age of people who have Blast cell count increased when taking Cytarabine? *

What are other drugs people take besides Cytarabine? *

What are other side effects people have besides Blast cell count increased? *

Thrombocytopenia (decrease of platelets in blood): 18 people, 30.00%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 11 people, 18.33%
Pneumonia: 11 people, 18.33%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 10 people, 16.67%
Febrile Neutropenia (fever with reduced white blood cells): 9 people, 15.00%
Anaemia (lack of blood): 8 people, 13.33%
Fever: 8 people, 13.33%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 7 people, 11.67%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 6 people, 10.00%
Subdural Haematoma (blood collects between the skull and the surface of the brain): 6 people, 10.00%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 37 people, 61.67%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 4 people, 6.67%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 4 people, 6.67%
Fever: 3 people, 5.00%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 3.33%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 3.33%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 3.33%
Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 2 people, 3.33%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 1.67%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 1.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cytarabine and have Blast cell count increased?

- Check whether Blast cell count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cytarabine:

Cytarabine (65,358 reports)

Browse all side effects of Cytarabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blast cell count increased:

Blast cell count increased (113 drugs)

Browse all the conditions that are associated with Blast cell count increased:

Blast cell count increased (181 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cytarabine (the active ingredients of Cytarabine) and Cytarabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.